Skip to main content

Table 1 Myopathies, transcripts, and deep intronic variants included in the NGS panel

From: The Latin American experience with a next generation sequencing genetic panel for recessive limb-girdle muscular weakness and Pompe disease

Myopathy

Name

Gene

Transcript

Exons

Intronic Variants

LGMD R1

calpain3-related

Calpainopathy

CAPN3

NM_000070

24

1746-20C > G; 2264-11C > T; 2381-12A > G

LGMD R2

dysferlin-related

Dysferlinopathy

DYSF

NM_003494

55

-116delC; 2163-11G > A; 2355 + 14G > A; 3442 + 14C > T

LGMD R5

γ-sarcoglycan-related

γ-sarcoglycanopathy

SGCG

NM_000231

7

 

LGMD R3

α-sarcoglycan-related

α-sarcoglycanopathy

SGCA

NM_000023

9

158-11G > A

LGMD R4

β-sarcoglycan-related

β-sarcoglycanopathy

SGCB

NM_000232

6

 

LGMD R6

δ-sarcoglycan-related

δ-sarcoglycanopathy

SGCD

NM_000337

9

 

LGMD R7

telethonin-related

Telethoninopathy

TCAP

NM_003673

2

 

LGMD R9

FKRP-related

 

FKRP

NM_024301

1

 

LGMD R12

anoctamin5-related

 

ANO5

NM_213599

22

 

Pompe Disease (PD)

 

GAA

NM_000152

19

2481 + 16G > A; 2800-11C > G; -32-13 T > G

Total

154

Â